ATLASRallybio (RLYB) earnings date: expected January 16–22
Rallybio (RLYB) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around January 16–22. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RLYB
| Last price | $15.77 (+1.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.9% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 6 reports |
These figures come from the same calibrated model and valuation as the Rallybio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 16–22 (estimate). One email the day before, with ATLAS’s read on Rallybio. You can switch it off at any time.
Alert me before RLYB reportsFree to start. Creating an account takes under a minute.
Notify me when Rallybio reports
Track RLYB free Add Rallybio to a free ATLAS watchlist and see its next report date in one place.
RLYB earnings at a glance
| Next report | Not announced · expected around January 16–22 (ATLAS estimate) |
|---|---|
| Last report | Oct 27, 2026 · Miss |
| Beat rate (last 6 reports) | 3 of 6 (50%) |
| Average EPS surprise | +18.2% |
| Average move around a report | ±2.2% (last 6) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Rallybio’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Rallybio earnings history: last 6 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 27, 2026 | – | -$0.48 | – | Miss | -4.0% |
| Aug 6, 2026 | -$1.28 | -$0.85 | +33.6% | Beat | +0.1% |
| Jul 28, 2026 | $2.80 | $2.84 | +1.4% | In line | -2.2% |
| May 13, 2026 | -$1.20 | -$1.46 | -21.7% | Miss | +1.3% |
| Apr 28, 2026 | $4.82 | $4.97 | +3.1% | Beat | +1.1% |
| Mar 27, 2026 | -$3.78 | -$0.97 | +74.3% | Beat | -4.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RLYB
See the fair value, the probability range and the earnings history of Rallybio on its ATLAS page.
Rallybio (RLYB) stock analysisPlans from €3.99 a month.
Rallybio earnings: frequently asked questions
When is Rallybio (RLYB) next earnings date?
Rallybio has not announced its next report. Its last 3 reports came Oct 27, 2026, Aug 6, 2026, May 13, 2026, so ATLAS estimates the next one around January 16–22. This is an estimate based on that pattern, not a confirmed date.
How often does RLYB beat earnings estimates?
Of its last 6 reports with a recorded result, Rallybio beat the EPS estimate 3 times; the average surprise was +18.2%. Past results do not predict the next one.
How much does RLYB move around earnings?
Over its last 6 reports the stock moved an average of 2.2% (absolute, from the close before the report day to the close after it), and finished higher 3 of 6 times.
How much does RLYB usually move in a day?
On a normal trading day the ATLAS model puts RLYB’s one-day range at about ±2.9%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer